VRX : Summary for Valeant Pharmaceuticals Interna - Yahoo Finance

U.S. Markets closed

Valeant Pharmaceuticals International, Inc. (VRX)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
16.40+0.36 (+2.24%)
At close: 4:02PM EST

16.32 -0.08 (-0.49%)
After hours: 7:50PM EST

People also watch
AGNGILDENDPBIIBFIT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close16.04
Open16.28
Bid0.00 x
Ask0.00 x
Day's Range16.13 - 16.47
52 Week Range13.00 - 86.50
Volume9,435,692
Avg. Volume14,893,232
Market Cap5.6B
Beta-1.01
PE Ratio (TTM)-2.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals4 hours ago

    ​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal

    EyeGate Pharmaceuticals, an 11-employee biotech headquartered in Waltham, saw its market cap more than double on Tuesday after announcing a licensing deal with Valeant Pharmaceuticals that could be worth up to $103 million. Under the deal, EyeGate received a $4 million upfront payment. As of 3 p.m. Tuesday afternoon, shares of EyeGate had increased by nearly 130 percent, boosting the company’s market cap from $15.7 million to almost $36 million.

  • TheStreet.com5 hours ago

    Valeant Acquires Eyegate Licensing Rights

    The company paid $4 million up front for the licensing rights for Eyegate's drop device.

  • 24/7 Wall St.10 hours ago

    Tuesday’s Top Biopharma Movers

    A few biopharma companies have made massive runs on Tuesday morning.